Despite their incredible clinical precision, molecular diagnostics face several operational and economic challenges, including high setup costs for specialized laboratory equipment, complex infrastructure requirements, and the necessity for highly trained technical personnel. Additionally, turnaround times can vary, supply chains for proprietary chemical reagents can face disruptions, and navigating stringent regulatory approvals or insurance reimbursement criteria poses ongoing hurdles for commercial laboratories.